Hypercholesterolaemia (Familial)

Identification and management of FH.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)

Last reviewed: 21 October 2025

CardiologyGenetics

Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.Find reviewed question practiceChoose your examination. iatroX will check for an exact reviewed question set before offering a topic; no filter or session starts automatically.

regional clinical guidance

Hypercholesterolaemia (Familial): guidance by region

Recommendations, thresholds and pathways can differ. Open the page written for the jurisdiction you need.

United StatesFamilial hypercholesterolemiaCardiovascular · reviewed 2026-08-20 CanadaFamilial hypercholesterolaemia (FH)Cardiovascular · reviewed 2026-08-20 AustraliaFamilial hypercholesterolaemia (FH): source-status boundaryCardiovascular · reviewed 2026-08-20

Clinical Guidelines

CKS: Hypercholesterolaemia - familial

ESC Guidelines on Dyslipidaemias (Management of)

NICE guideline [CG71]

NICE guideline [CG71]: Familial hypercholesterolaemia: identification and management

NICE guideline [CG71]: Familial hypercholesterolaemia: identification and management - Recommendations

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice (JBS2)

NICE Clinical Knowledge Summary: Hypercholesterolaemia - familial